Adding mycophenolate mofetil to usual radiation and chemo for brain cancer
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether adding a drug called mycophenolate mofetil to the standard treatment (radiation therapy and temozolomide) helps people with a newly diagnosed brain cancer called glioblastoma. The drug may boost the effect of the standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a type of brain cancer called glioblastoma.
- You are 18 years or older.
- You have not had any prior treatment for glioblastoma except surgery to remove the tumor.
- Your surgery was at least 2 weeks ago and you have healed well.
- You are able to take medications by mouth and undergo MRI scans.
- You are generally healthy enough to receive standard chemoradiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether liposomal curcumin, added to standard radiation plus temozolomide, can improve treatment outcomes in newly diagnosed high-grade gliomas. It focuses on safety and how well the treatment can be given with the usual therapy plan.
This trial tests whether adding the drug ruxolitinib to standard radiation and chemotherapy (temozolomide) helps people with a newly diagnosed brain tumor called glioblastoma. It aims to see if the combination keeps the tumor from growing longer than the standard treatment alone.
This study tests a new medicine (MT-125) combined with standard radiation and chemotherapy for people with newly diagnosed glioblastoma that has a specific gene change (MGMT methylated). The goal is to see if it is safe and tolerable, and to look for early signs it might help.
This trial compares two standard treatments for newly diagnosed glioblastoma (a serious brain cancer) in older and frail patients: chemo plus radiation versus chemo alone. It may help determine which approach works best and is safest for people in your age and health group.
This trial is testing whether a drug called G-CSF (which helps boost white blood cells) can help people with glioblastoma who are already receiving standard treatment with radiation and chemotherapy (temozolomide). It aims to see if G-CSF can reduce side effects and improve outcomes.
This trial tests giving a chemotherapy drug called temozolomide before radiation therapy to people with a newly diagnosed high-grade brain tumor. The goal is to see if this approach can help control the tumor better.
Hear when a new Advanced Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.